Menopause
Commentary
A new nonhormonal option for menopausal hot flashes: What prescribers should know
In two phase 3 clinical trials, fezolinetant 45 mg reduced the frequency of vasomotor symptoms by about 65%.
From the Journals
Hormone therapies still ‘most effective’ in treating menopausal vasomotor symptoms
Clinicians should individualize menopause care to each patient.
From the Journals
Nitroglycerin patches do not improve menopause symptoms
“The menopause field is still lacking in effective treatment approaches that don’t involve hormones,” said Dr. Alison Huang.
Feature
Menopause and long COVID: What women should know
Women at midlife who have long COVID seem to get specific, and severe, symptoms, including brain fog, fatigue, new-onset dizziness, and difficulty...
Latest News
FDA approves new drug to manage menopausal hot flashes
Fezolinetant (Veozah) targets the neural activity behind moderate to severe vasomotor symptoms.
Conference Coverage
BMI has greater impact on survival in younger breast cancer patients
Study of women on endocrine therapy for breast cancer addresses the effects of BMI on survival.
From the Journals
Early menopause, delayed HT tied to Alzheimer’s pathology
The link between HT, dementia, and cognitive decline has been hotly debated since the initial release of findings from the Women’s Health...
Latest News
Ospemifene and HT boost vaginal microbiome in vulvovaginal atrophy
Systemic hormone treatment induced changes in minority bacterial groups in the vaginal microbiome, whereas ospemifene eliminated specific harmful...
Feature
HRT may prevent Alzheimer’s in high-risk women
Results from a cohort study showed that use of HRT was associated with larger entorhinal and hippocampal brain volumes.
Latest News
Does subclinical hyperthyroidism raise fracture risk?
In considering whether to treat osteoporosis, subclinical hyperthyroidism “may be enough to tip the balance in favor of pharmacological therapy...
Guidelines
USPSTF holds firm on postmenopausal hormone recommendations
The central message of updated recommendations from the U.S. Preventive Services Task Force’s on using hormone therapy to prevent chronic...